349 related articles for article (PubMed ID: 27472505)
1. Advances in modeling and treating spinal muscular atrophy.
Van Alstyne M; Pellizzoni L
Curr Opin Neurol; 2016 Oct; 29(5):549-56. PubMed ID: 27472505
[TBL] [Abstract][Full Text] [Related]
2. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
[TBL] [Abstract][Full Text] [Related]
3. Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
Nash LA; Burns JK; Chardon JW; Kothary R; Parks RJ
Curr Mol Med; 2016; 16(9):779-792. PubMed ID: 27894243
[TBL] [Abstract][Full Text] [Related]
4. SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.
Khairallah MT; Astroski J; Custer SK; Androphy EJ; Franklin CL; Lorson CL
Hum Mol Genet; 2017 Mar; 26(5):932-941. PubMed ID: 28062667
[TBL] [Abstract][Full Text] [Related]
5. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
[TBL] [Abstract][Full Text] [Related]
6. Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models.
Kim JK; Jha NN; Feng Z; Faleiro MR; Chiriboga CA; Wei-Lapierre L; Dirksen RT; Ko CP; Monani UR
J Clin Invest; 2020 Mar; 130(3):1271-1287. PubMed ID: 32039917
[TBL] [Abstract][Full Text] [Related]
7. Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy.
Lee AJ; Awano T; Park GH; Monani UR
PLoS One; 2012; 7(9):e46353. PubMed ID: 23029491
[TBL] [Abstract][Full Text] [Related]
8. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
[TBL] [Abstract][Full Text] [Related]
9. Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway.
D'Amico D; Biondi O; Januel C; Bezier C; Sapaly D; Clerc Z; El Khoury M; Sundaram VK; Houdebine L; Josse T; Della Gaspera B; Martinat C; Massaad C; Weill L; Charbonnier F
Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12816. PubMed ID: 35338505
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.
Laird AS; Mackovski N; Rinkwitz S; Becker TS; Giacomotto J
Hum Mol Genet; 2016 May; 25(9):1728-38. PubMed ID: 26908606
[TBL] [Abstract][Full Text] [Related]
11. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
[TBL] [Abstract][Full Text] [Related]
12. Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.
Anderton RS; Meloni BP; Mastaglia FL; Boulos S
Mol Neurobiol; 2013 Apr; 47(2):821-32. PubMed ID: 23315303
[TBL] [Abstract][Full Text] [Related]
13. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
[TBL] [Abstract][Full Text] [Related]
14. What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective.
Blatnik AJ; McGovern VL; Burghes AHM
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445199
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
16. Hyperexcitability precedes motoneuron loss in the
Quinlan KA; Reedich EJ; Arnold WD; Puritz AC; Cavarsan CF; Heckman CJ; DiDonato CJ
J Neurophysiol; 2019 Oct; 122(4):1297-1311. PubMed ID: 31365319
[TBL] [Abstract][Full Text] [Related]
17. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
[TBL] [Abstract][Full Text] [Related]
18. The water extract of Liuwei dihuang possesses multi-protective properties on neurons and muscle tissue against deficiency of survival motor neuron protein.
Tseng YT; Jong YJ; Liang WF; Chang FR; Lo YC
Phytomedicine; 2017 Oct; 34():97-105. PubMed ID: 28899515
[TBL] [Abstract][Full Text] [Related]
19. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
20. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
